Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Dr Steven Leventer to head up neuroscience research for PharmaNet

February 17, 2010 Research and Development PharmaNet, appointment, research and development

PharmaNet Development Group has named Dr Steven Leventer to the position of vice president, clinical research – neuroscience. Leventer joins …
Appointment
immaticslogoJPG72dpi

Immatics vaccine trials to be conducted with Cancer Research UK

February 16, 2010 Research and Development immatics, vaccines

Cancer Research Technology, the development and commercial arm of Cancer Research UK, has reached an agreement to collaborate with German-based …
News

MDS completes contract research exit

February 15, 2010 Research and Development CRO, mds

MDS has completed the sell-off of its contract research and development business – MDS Pharma Services – with the signing …
News

Amarin appoints Jan van Heek

February 15, 2010 Research and Development, Sales and Marketing Amarin, appointment, research and development, sales and marketing

Jan van Heek has joined Amarin’s board of directors of as a non-executive director and will also take on the role …
Appointment

Contract research news in brief

February 15, 2010 Research and Development Almac Pharma Services, CRO, CoreLab Partners, DreamCIS, PPD, Parexel, Proteome Sciences, SIRO Clinpharm, Thermo Fisher Scientifitic

Our round-up of developments in the contract research sector includes alliances for Parexel/Proteome Sciences and SIRO Clinpharm/DreamCIS, as well as …
News

Management Forum Announces Pharmacy 2010 – Exhibition Website

February 11, 2010 Research and Development

Management Forum is pleased to announce the launch of their PHARMACY 2010 Exhibition website.  This exciting new website contains full …
News
Press release

Roche diabetes trial proves promising

February 11, 2010 Research and Development GLP-1, Roche, diabetes, taspoglutide

Phase III results for Roche’s once-weekly injectable drug taspoglutide have shown a positive effect on reducing blood glucose compared with …
News

Oral strip ondansetron held up at FDA

February 11, 2010 Manufacturing and Production, Research and Development Strativa, chemotherapy, film strips, nausea

A novel formulation of ondansetron has seen its marketing application delayed at the US Food and Drug Administration (FDA) because …
News

GSK to downsize Harlow R&D site

February 10, 2010 Research and Development GlaxoSmithKline, job cuts

GlaxoSmithKline is on the point of making the first job cuts in a round of redundancies designed to save £500 …
News
Novartis' Olivier Leupin

Working Life: Olivier Leupin

February 9, 2010 Business Services, Research and Development Novartis, Working Life, careers, careers voice

How did you find your way into your most current role? After receiving a master’s degree in biology at the …
Feature

ICON promotes Tom O’Leary

February 9, 2010 Research and Development ICON, appointment, research and development

Tom O’Leary has been appointed president of ICON Central Laboratories, succeeding Bob Scott-Edwards. Scott-Edwards had held the role since August …
Appointment

Pfizer to personalise brain tumour vaccine

February 8, 2010 Research and Development Pfizer, Qiagen, brain tumour, gliobastoma, vaccines

Pfizer is working with Dutch company Qiagen to develop a companion diagnostic kit for its immunotherapy vaccine for gliobastoma multiforme. …
News
Blog footer

Digital Pharma: UCB’s online epilepsy community

February 8, 2010 Medical Communications, Research and Development PatientsLikeMe, UCB, community, digital pharma, digital pharma research, patient information

UCB has launched an online community for US epilepsy patients to record ‘real-world’ experiences of the condition. In addition to …
Feature

GSK looks to rare diseases research

February 5, 2010 Research and Development GlaxoSmithKline, Orphan

GlaxoSmithKline has launched a new specialist unit to research and develop medicines for rare diseases. The company has identified 5,500 …
News
ABPI

Barker praises OLS model

February 5, 2010 Research and Development, Sales and Marketing ABPI, Blueprint, OLS

The ABPI’s director general spoke to Pharmafocus about the promise of the new Blueprint at its launch in London last …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026